• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Event Tracking

Dec13
2025 National Medical Insurance Drug Directory Update, Hengrui and Eli Lilly are Major Winners
03:47
Dec12
China Resources Land Announces Sales Performance and Regular Income for January to November 2025
13:20
Yuexiu Properties Reports 49% Drop in Sales in November 2025
12:05
Hengrui Medicine's Subsidiary Receives Clinical Trial Approval Notice for RSS0343 Tablets from NMPA
11:57
HRS9531 Injection Approved for Clinical Trials by Huahai Medicine's Subsidiary
11:53
Morgan Stanley Reduces Its Holding in Hengrui Medicine
09:22